Green

Protecting the environment

When we challenge our impact on the environment,

We advance ways to protect it

HeartLogic™ Heart Failure Diagnostic

Boston Scientific's HeartLogic is an innovative solution for personalized and remote heart failure diagnostic and monitoring.

2% of healthcare spend

2% of healthcare spend

Heart Failure represents

A significant clinical, economic, and environmental burden. The disease accounts for 2% of healthcare spend, 60-70% of which is related to hospitalisations.1,2

Icon showing group of 3 people.

Predictive algorithm

Digital Diagnostic

HeartLogic is a digital diagnostic technology, which can be used alongside remote monitoring, in the management of heart failure patients implanted with a CRT-D or ICD device. The technology employs a predictive algorithm, to provide advanced notice of worsening heart failure.

Icon showing group of 3 people.

74% reduction in hospitalizations

Reduce hospitalizations

HeartLogic is proven to reduce hospitalizations for decompensated heart failure by 74% and hospitalization length of stay by 56%.6 This could significantly reduce resource utilization, waste per patient and greenhouse gas (GHG) emissions for the healthcare system.3,4

Green

HeartLogic™

Learn how HeartLogic works and how it’s advanced the way clinicians care for heart failure patients

Know more

HeartLogic impact on GHG emissions per patient per year*

Clouds

Without HeartLogic 236.5kg*

Clouds

With HeartLogic 29.2kg*

This equates to a reduction of

88% In greenhouse gas emissions7

* Estimates based on rate and mean length of stay for heart failure admissions reported in Treskes et al. (2021) and data from sustainable care pathways guidance: Inpatient bed day.7 Estimates exclude impact of non-inpatient care prior to admission (e.g., primary care support or acute medical unit management), possible surgical treatment or visitors during hospital stay.

Waste Reduction

Hospital

A hospital can produce more than 480 tonnes of waste each year.5

Hospital Bed

3 to 13 kg of total waste is generated per patient per bed day depending on level of acuity.4

An estimated 20-25% is plastic waste.5

An estimated 20-25% is plastic waste.5

People

If 1,000 heart failure patients...

HeartLogic™ heart failure diagnostics.

...were monitored using HeartLogic™ heart failure diagnostics...

Truck

…there could be a reduction of up to 71 tonnes of waste which equates to an 88% decrease in waste per 1,000 patients per year.6

What’s Next?

Boston Scientific joined the United Nations Race to Zero and Business Ambition for 1.5°C campaign and is committed to set a science-based target through the Science Based Targets initiative that will put us on a path to achieve net-zero emissions across our entire value chain by 2050.

References:

  1. NICE Resource impact report: Chronic heart failure in adults: diagnosis and management (NG106) https://www.nice.org.uk/guidance/ng106/resources/resource-impact-report-pdf-6537494413
  2. Cowie, Martin R. “The heart failure epidemic: a UK perspective.” Echo research and practice vol. 4,1 (2017): R15-R20.doi:10.1530/ERP-16-0043. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435875
  3. Treskes, Roderick W., et al. "Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients.” ESC Heart Failure 8.2 (2021): 1541-1551.
  4. Sustainable Care Pathways Guidance: Inpatient bed day module published 2015, Surgical Procedure Module Published 2015 Sustainable Care Pathways Guidance – Sustainable Healthcare Coalition: (https://shcoalition.org/sustainable-care-pathways-guidance).
  5. Lee, Byeong-Kyu & Ellenbecker, Michael & Moure-Eraso, Rafael. (2002). Analyses of the recycling potential of medical plastic wastes. Waste management (New York, N.Y.). 22.461-70.10.1016/S0956-053X(02)00006-5.
  6. Data on file Boston Scientific.

CAUTION:

The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.